Institute for Clinical & Economic Review, One State Street, Suite 1050, Boston, MA 02109, USA.
J Comp Eff Res. 2014 Jan;3(1):53-61. doi: 10.2217/cer.13.82.
Economic modeling has rarely been considered to be an essential component of healthcare policy-making in the USA, due to a lack of transparency in model design and assumptions, as well as political interests that equate examination of cost with unfair rationing. The Institute for Clinical and Economic Review has been involved in several efforts to bring economic modeling into public discussion of the comparative value of healthcare interventions, efforts that have evolved over time to suit the needs of multiple public forums. In this article, we review these initiatives and present a template that attempts to 'unpack' model output and present the major drivers of outcomes and cost. We conclude with a series of recommendations for effective presentation of economic models to US policy-makers.
经济建模在美国很少被认为是医疗保健政策制定的一个必要组成部分，这是由于模型设计和假设缺乏透明度，以及将成本审查等同于不公平的配给的政治利益。临床和经济审查学会参与了多项努力，将经济建模纳入医疗保健干预措施比较价值的公共讨论，这些努力随着时间的推移而发展，以适应多个公共论坛的需求。在本文中，我们回顾了这些举措，并提出了一个模板，试图“拆开”模型输出，并呈现结果和成本的主要驱动因素。我们最后为向美国政策制定者有效展示经济模型提出了一系列建议。
